Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms

Circulation

Volumn 105, Issue 15, 2002, Pages 1861-1870

  Young, Martin E ^a   McNulty, Patrick ^a   Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascutar diseases; Diabetes mellitus; Heart failure

Indexed keywords

FATTY ACID; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADAPTATION; DIABETES MELLITUS; FATTY ACID METABOLISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART DISEASE; HEART MUSCLE METABOLISM; HUMAN; METABOLIC DISORDER; METABOLIC REGULATION; PRIORITY JOURNAL; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM-TRANSPORTING ATPASES; CONTRACTILE PROTEINS; DIABETIC ANGIOPATHIES; FATTY ACIDS; GLUCOSE; HEART; HEART DISEASES; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; MYOCARDIUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSCRIPTION, GENETIC;

EID: 0037117651     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000012467.61045.87     Document Type: Review

References (117)

1. Cellular mechanisms of cardiac hypertrophy
2. Signaling in myocardial hypertrophy
3. Signaling pathways for cardiac hypertrophy and failure
4. Cytoplasmic signaling pathways that regulate cardiac hypertrophy
5. GLUT4 vesicle dynamics in living 3T3 L1 adipocytes visualized with green-fluorescent protein
6. 18F-2-deoxy-2-fluoro-D-glucose
7. Regulation of energy metabolism of the heart during acute increase in heart work
8. Alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart
9. The hormonal control of glycogen metabolism in mammalian muscle by multisite phosphorylation
10. What if Minkowski had been ageusic? An alternative angle on diabetes
11. Metabolic fuel selection: General integration at the whole-body level
12. Utilization of energy providing substrates in the isolated working rat heart
13. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling
14. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
15. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
16. Regulation of gene expression by dietary fat
17. The fluid mosaic model of the structure of cell membranes
18. Banting lecture 1988. Role of insulin resistance in human disease
19. Malonyl-CoA, fuel sensing, and insulin resistance
20. Lipotoxic heart disease in obese rats: Implications for human obesity
21. A novel mouse model of lipotoxic cardiomyopathy
22. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression
23. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
24. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPARalpha-null mouse as a model of fatty acid oxidation disorders
25. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha
26. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes
27. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids
28. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart
29. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes
30. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors
31. PPAR signaling in the control of cardiac energy metabolism
32. Peroxisome proliferator-activated receptor gamma coactivator-I promotes cardiac mitochondrial biogenesis
33. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
34. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat
35. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemla and reperfusion
36. Palmitate-induced apoptosis can occur through a ceramide-independent pathway
37. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation
38. Reduced O glycosylation of SpI is associated with increased proteasome susceptibility
39. Glycosylation of eukaryotic peptide chain initiation factor 2 (elF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of elF-2 kinase-catalyzed phosphorylation of the elF-2 alpha-subunit
40. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats
41. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: Prevention by alpha-tocopherol?
42. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes
43. Regulation of gene expression by glucose
44. Glucose regulation of gene transcription
45. Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter
46. Glucose regulation of gene expression
47. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADDI/SREBP1
48. SREBP-I, a membrane-bound transcription factor released by sterol-regulated proteolysis
49. Two glucose-signaling pathways in S14 gene transcription in primary hepatocytes: A common role of protein phosphorylation
50. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes
51. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle
52. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport
53. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside
54. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
55. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes
56. Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway
57. Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase
58. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-G1cNAc
59. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo
60. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
61. Overexpression of glutamine: Fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance
62. Sp1 mediates glucose activation of the acety1 Co-A carboxylase promoter
63. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
64. Mitochondrial carnitine palmitoyl-tranferase isoform switching in the developing rat heart
65. Maturation of fatty acid and carbohydrate metabolism in the newborn heart
66. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins: Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase
67. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts
68. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats: A quantitative autoradiographic study
69. Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro
70. Regulation of pyruvate oxidation and the conservation of glucose
71. Regulation of energy substrate metabolism in the diabetic heart
72. Studies on myocardial metabolism IV myocardial metabolism in diabetes
73. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
74. The effects of acute and chronic diabetes on myocardial metabolism in rats
75. Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat
76. [5-3H]glucose overestimates glycolytic flux in isolated working rat heart: Role of the pentose phosphate pathway
77. Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart
78. Reactivation of peroxisome proliferator-activated receptor (alpha) is associated with contractile dysfunction in hypertrophied rat heart
79. M-Cat, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth
80. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction
81. Diabetes mellitus induces changes in cardiac myosin of the rat
82. Methyl palmoxirate increases Ca2+-myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart
83. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir
84. Isolation and characterization of the mouse cardiac myosin heavy chain genes
85. Identification of a contractile-responsive element in the cardiac alpha-myosin heavy chain gene
86. Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone
87. Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy
88. Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes
89. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir
90. Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum
91. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor
92. Modification of myosin isozymes and SR Ca(2+)-pump ATPase of the diabetic rat heart by lipid-lowering interventions
93. Transcriptional modulators targeted at fuel metabolism of hypertrophied heart
94. Modulation of cardiac sarcoplasmic reticulum gene expression by lack of oxygen and glucose
95. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene
96. A malonyl-CoA fuel-sensing mechanism in muscle: Effects of insulin, glucose, and denervation
97. Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta -cell
98. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth
99. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophy growth program
100. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships
101. Diseases of liporegulation: New perspective on obesity and related disorders
102. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy
103. Hypertensive-diabetic cardiomyopathy in the rat: An experimental model of human disease
104. Cardiovascular abnormalities associated with human and rodent obesity
105. Effects of insulin perfusion and altered glucose concentrations on heart function in 3-day and 6-week diabetic rats
106. Contribution of matony-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart
107. Hexosamines and insulin resistance
108. Redox regulation of cardiac muscle calcium signaling
109. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction
110. Recent advances toward understanding redox mechanisms in the activation of nuclear factor kappaB
111. Role of reactive oxygen species (ROS) in apoptosis induction
112. Structural and functional characterization of the mouse fatty acid translocase promoter: Activation during adipose differentiation
113. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene
114. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?
115. A role for PPAR{alpha} in the control of cardiac malony1-CoA levels: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPAR{alpha} are associated with higher concentrations of malony1-CoA and reduced expression of malony1-CoA decarboxylase
116. Induction of the acy1-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter